Developer docs
API playgroundTry for free, no card

Search company profiles

UltraShape Ltd. (Syneron Medical)

Full company profile

uuid003b98l

Namestring
UltraShape Ltd. (Syneron Medical)
Legal namestring
Candela Corporation
Websiteurl
ultrashape.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

UltraShape Ltd. operates as a non-invasive body-shaping technology provider within the Syneron Medical / Candela Corporation aesthetic device portfolio. UltraShape's original FDA-cleared modality uses focused, pulsed ultrasound energy to selectively destroy fat cells without surgery, targeting the non-invasive fat-reduction segment of medical aesthetics. The technology was originally developed and commercialized as a standalone company before being acquired by Syneron Medical, which later rebranded the combined entity as Candela Corporation; UltraShape now sits alongside Candela's broader laser, IPL, RF microneedling, and hydrodermabrasion product family.

Under the Candela umbrella, the combined business sells capital-equipment aesthetic treatment systems — including Nordlys (IPL/laser), PicoWay (picosecond laser), Vbeam (pulsed-dye laser), Gentle Pro Series (laser hair removal), Matrix (RF microneedling), and Glacē (hydrodermabrasion) — directly to medical providers such as dermatologists, plastic surgeons, general doctors, hospitals, and med spas. Revenue is generated primarily through hardware sales of these systems to practitioner customers, with no publicly disclosed pricing or per-treatment economics.

The go-to-market operates as a B2B-to-B2C model: the company reaches patients indirectly through provider channels rather than delivering treatments directly, and supports this with a patient-facing website (localized into six languages) that hosts treatment education, brand portfolio information, and a "Find a Treatment Provider" tool to funnel consumer demand to installed-base providers. The company is US-based (Wayland, MA), private, and operates with 101-250 employees, serving global markets through direct field sales and international distribution.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersWayland, United States
HQ citystring
Wayland
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
medical aesthetic devices, aesthetic laser systems, non-invasive body shaping, focused ultrasound fat reduction, dermatology treatment equipment
Industry1 code
1Laser & Energy-Based Dermatology
CodeHLAKACAFPrimaryYes
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical and Medical Instrument Manufacturing339112
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Aesthetic Devices
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Aesthetic Device Sales
TypeHardware Sales
Description

Sale of laser and light-based aesthetic treatment systems to medical providers including dermatologists, plastic surgeons, hospitals, and med spas. These are capital equipment purchases for medical practices.

candelamedical.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Supply Chain, Technology or R&D, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1Nordlys®
Description

Intense pulsed light (IPL) treatment for acne, vascular conditions, hair removal, and skin texture

candelamedical.com
+5 more records
Core offering1 text field

UltraShape is an FDA-cleared, non-invasive body-shaping procedure that uses focused, pulsed ultrasound energy to selectively destroy fat cells. The company manufactures and sells medical aesthetic devices including laser systems (Nordlys IPL, PicoWay picosecond laser, Vbeam pulsed-dye laser, Gentle Pro Series), radiofrequency microneedling (Matrix), and advanced hydrodermabrasion (Glacē) systems to dermatologists, plastic surgeons, hospitals, and med spas.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Candela offers a comprehensive portfolio of medical aesthetic devices for non-invasive and minimally invasive treatments. The product line includes laser systems (Nordlys® IPL/laser, PicoWay® picosecond laser, Vbeam® pulsed-dye laser, Gentle Pro™ Series laser), radiofrequency microneedling (Matrix™), and advanced hydrodermabrasion (Glacē™). These systems collectively address treatments for hair removal, hyperpigmentation, skin rejuvenation, skin resurfacing, tattoo removal, vascular lesions, scars, and stretch marks.

Product and service1 record
1Nordlys®
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Direct peer in non-invasive body shaping and skin tightening, with energy-based platforms (EMSCULPT, EMFACE, Exilis) that compete in adjacent body-contouring and facial-treatment indications. Same provider channel and B2B sales motion.

TypeDirect peer
Description

Direct peer in minimally invasive and energy-based aesthetic devices, particularly strong in RF microneedling (Morpheus8), body contouring, and laser platforms. Aggressive challenger in many of the same provider accounts as Candela.

TypeDirect peer
Description

Direct peer in laser and light-based aesthetic and medical devices, with comparable platforms in skin resurfacing, vascular treatments, and hair removal. Sells into plastic surgery and dermatology practices with a similar premium capital equipment model.

TypeDirect peer
Description

Direct peer in the medical aesthetic laser and energy-based device market, with overlapping product lines in hair removal, skin revitalization, and body contouring. Comparable B2B-to-provider sales motion and similar end customer mix of dermatologists, plastic surgeons, and med spas.

TypeBroad incumbent
Description

Broad incumbent in the broader medical aesthetics market via injectables (Botox, fillers) and the SkinMedica skincare line. Not a direct device competitor, but operates in the same provider offices and end-patient demand pool, shaping purchase decisions for energy-based device add-ons like Candela's portfolio.

TypeDirect peer
Description

Direct peer in energy-based aesthetic devices, offering laser, RF, and PEMF-based platforms. Targets a similar mix of dermatologists, plastic surgeons, and med spas with a subscription-based business model twist on the same provider channel.

TypeDirect peer
Description

Direct peer in aesthetic lasers and energy-based devices for hair removal, skin revitalization, and body sculpting. Sells into the same dermatologist, plastic surgeon, and med-spa channels with comparable capital equipment sales motion.

TypeDirect peer
Description

Direct peer offering a multi-modality portfolio of laser, IPL, RF, and ultrasound-based aesthetic platforms. Targets the same dermatologist, plastic surgeon, and med-spa customer base with a comparable global distribution footprint.

TypeDirect peer
Description

Direct peer with established brands (Thermage, Fraxel, Clear+Brilliant, Liposonix) overlapping Candela's RF microneedling (Matrix) and laser skin rejuvenation lines. Comparable B2B model into the same provider end markets.

TypeDirect peer
Description

Direct peer in energy-based aesthetic devices, particularly strong in IPL and CO2 laser systems. Now part of Boston Scientific's aesthetics franchise, competing head-to-head with Candela's Nordlys and Vbeam franchises in dermatology practices.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

UltraShape Ltd. (Syneron Medical)

Medical Aesthetic Devicesultrashape.com

What UltraShape Ltd. (Syneron Medical) does

UltraShape Ltd. operates as a non-invasive body-shaping technology provider within the Syneron Medical / Candela Corporation aesthetic device portfolio. UltraShape's original FDA-cleared modality uses focused, pulsed ultrasound energy to selectively destroy fat cells without surgery, targeting the non-invasive fat-reduction segment of medical aesthetics. The technology was originally developed and commercialized as a standalone company before being acquired by Syneron Medical, which later rebranded the combined entity as Candela Corporation; UltraShape now sits alongside Candela's broader laser, IPL, RF microneedling, and hydrodermabrasion product family.

Under the Candela umbrella, the combined business sells capital-equipment aesthetic treatment systems — including Nordlys (IPL/laser), PicoWay (picosecond laser), Vbeam (pulsed-dye laser), Gentle Pro Series (laser hair removal), Matrix (RF microneedling), and Glacē (hydrodermabrasion) — directly to medical providers such as dermatologists, plastic surgeons, general doctors, hospitals, and med spas. Revenue is generated primarily through hardware sales of these systems to practitioner customers, with no publicly disclosed pricing or per-treatment economics.

The go-to-market operates as a B2B-to-B2C model: the company reaches patients indirectly through provider channels rather than delivering treatments directly, and supports this with a patient-facing website (localized into six languages) that hosts treatment education, brand portfolio information, and a "Find a Treatment Provider" tool to funnel consumer demand to installed-base providers. The company is US-based (Wayland, MA), private, and operates with 101-250 employees, serving global markets through direct field sales and international distribution.

UltraShape Ltd. (Syneron Medical) firmographics

Firmographics
Name
UltraShape Ltd. (Syneron Medical)
Legal name
Candela Corporation
Website
https://ultrashape.com
Company type
Private
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

UltraShape Ltd. (Syneron Medical) industry classification

Industry
Product category
Medical Aesthetic Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Laser & Energy-Based Dermatology (HLAKACAF)

Keywords

  • Medical aesthetic devices
  • Aesthetic laser systems
  • Non-invasive body shaping
  • Focused ultrasound fat reduction
  • Dermatology treatment equipment

Where UltraShape Ltd. (Syneron Medical) is headquartered

Location

Headquarters

HQ city
Wayland
HQ country
United States
HQ region
North America

Markets served

UltraShape Ltd. (Syneron Medical) business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Medical Aesthetic Device Sales: Sale of laser and light-based aesthetic treatment systems to medical providers including dermatologists, plastic surgeons, hospitals, and med spas. These are capital equipment purchases for medical practices.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

UltraShape Ltd. (Syneron Medical) product offering

Product offering

Core offering

UltraShape is an FDA-cleared, non-invasive body-shaping procedure that uses focused, pulsed ultrasound energy to selectively destroy fat cells. The company manufactures and sells medical aesthetic devices including laser systems (Nordlys IPL, PicoWay picosecond laser, Vbeam pulsed-dye laser, Gentle Pro Series), radiofrequency microneedling (Matrix), and advanced hydrodermabrasion (Glacē) systems to dermatologists, plastic surgeons, hospitals, and med spas.

Product overview

Candela offers a comprehensive portfolio of medical aesthetic devices for non-invasive and minimally invasive treatments. The product line includes laser systems (Nordlys® IPL/laser, PicoWay® picosecond laser, Vbeam® pulsed-dye laser, Gentle Pro™ Series laser), radiofrequency microneedling (Matrix™), and advanced hydrodermabrasion (Glacē™). These systems collectively address treatments for hair removal, hyperpigmentation, skin rejuvenation, skin resurfacing, tattoo removal, vascular lesions, scars, and stretch marks.

Differentiator

Problem solved

Functional benefit

Brands

  • Nordlys®: Intense pulsed light (IPL) treatment for acne, vascular conditions, hair removal, and skin texture
  • PicoWay®
  • Vbeam®
  • Gentle Pro™ Series
  • Matrix™
  • Glacē™

Products and services

  • Nordlys®

Companies that use UltraShape Ltd. (Syneron Medical)

Customer profile

Named customers5 records

Segments2 records

Ideal customer profiles1 record

UltraShape Ltd. (Syneron Medical) technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

UltraShape Ltd. (Syneron Medical) partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

UltraShape Ltd. (Syneron Medical) competitors and assessment

Company assessment

Direct peers

  • BTL Aesthetics: Direct peer in non-invasive body shaping and skin tightening, with energy-based platforms (EMSCULPT, EMFACE, Exilis) that compete in adjacent body-contouring and facial-treatment indications. Same provider channel and B2B sales motion.
  • InMode: Direct peer in minimally invasive and energy-based aesthetic devices, particularly strong in RF microneedling (Morpheus8), body contouring, and laser platforms. Aggressive challenger in many of the same provider accounts as Candela.
  • Sciton: Direct peer in laser and light-based aesthetic and medical devices, with comparable platforms in skin resurfacing, vascular treatments, and hair removal. Sells into plastic surgery and dermatology practices with a similar premium capital equipment model.
  • Cynosure (Hologic): Direct peer in the medical aesthetic laser and energy-based device market, with overlapping product lines in hair removal, skin revitalization, and body contouring. Comparable B2B-to-provider sales motion and similar end customer mix of dermatologists, plastic surgeons, and med spas.
  • Venus Concept: Direct peer in energy-based aesthetic devices, offering laser, RF, and PEMF-based platforms. Targets a similar mix of dermatologists, plastic surgeons, and med spas with a subscription-based business model twist on the same provider channel.
  • Cutera: Direct peer in aesthetic lasers and energy-based devices for hair removal, skin revitalization, and body sculpting. Sells into the same dermatologist, plastic surgeon, and med-spa channels with comparable capital equipment sales motion.
  • Alma Lasers: Direct peer offering a multi-modality portfolio of laser, IPL, RF, and ultrasound-based aesthetic platforms. Targets the same dermatologist, plastic surgeon, and med-spa customer base with a comparable global distribution footprint.
  • Solta Medical (Bausch Health): Direct peer with established brands (Thermage, Fraxel, Clear+Brilliant, Liposonix) overlapping Candela's RF microneedling (Matrix) and laser skin rejuvenation lines. Comparable B2B model into the same provider end markets.
  • Lumenis (Boston Scientific Aesthetic Business): Direct peer in energy-based aesthetic devices, particularly strong in IPL and CO2 laser systems. Now part of Boston Scientific's aesthetics franchise, competing head-to-head with Candela's Nordlys and Vbeam franchises in dermatology practices.

Broad incumbents

  • AbbVie (Allergan Aesthetics): Broad incumbent in the broader medical aesthetics market via injectables (Botox, fillers) and the SkinMedica skincare line. Not a direct device competitor, but operates in the same provider offices and end-patient demand pool, shaping purchase decisions for energy-based device add-ons like Candela's portfolio.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

UltraShape Ltd. (Syneron Medical) social profiles

Digital presence

UltraShape Ltd. (Syneron Medical) financial estimates

Financial estimate

Revenue estimate

Valuation estimate

UltraShape Ltd. (Syneron Medical) leadership team

Management profile

Number of profiles

UltraShape Ltd. (Syneron Medical) funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

UltraShape Ltd. (Syneron Medical) M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UltraShape Ltd. (Syneron Medical)

What does UltraShape Ltd. (Syneron Medical) do?

UltraShape is an FDA-cleared, non-invasive body-shaping procedure that uses focused, pulsed ultrasound energy to selectively destroy fat cells. The company manufactures and sells medical aesthetic devices including laser systems (Nordlys IPL, PicoWay picosecond laser, Vbeam pulsed-dye laser, Gentle Pro Series), radiofrequency microneedling (Matrix), and advanced hydrodermabrasion (Glacē) systems to dermatologists, plastic surgeons, hospitals, and med spas.

Is UltraShape Ltd. (Syneron Medical) a public or private company?

UltraShape Ltd. (Syneron Medical) is a private company. It is classified as venture growth investor backed and is currently operating.

When was UltraShape Ltd. (Syneron Medical) founded?

UltraShape Ltd. (Syneron Medical) was founded in -1. It employs 101 to 250 people.

Where is UltraShape Ltd. (Syneron Medical) based?

UltraShape Ltd. (Syneron Medical) is headquartered in Wayland, United States, in the North America region.

How does UltraShape Ltd. (Syneron Medical) make money?

One revenue line is on record: medical Aesthetic Device Sales.

Who are UltraShape Ltd. (Syneron Medical)'s main competitors?

Direct peers on record are BTL Aesthetics, InMode, Sciton, Cynosure (Hologic), Venus Concept, Cutera, Alma Lasers, Solta Medical (Bausch Health) and Lumenis (Boston Scientific Aesthetic Business). AbbVie (Allergan Aesthetics) is listed as a broad incumbent.

Does UltraShape Ltd. (Syneron Medical) have an API?

No public API is recorded for UltraShape Ltd. (Syneron Medical).

What industry is UltraShape Ltd. (Syneron Medical) in?

UltraShape Ltd. (Syneron Medical)'s product category is Medical Aesthetic Devices. Its primary akta.pro industry code is HLAKACAF, Laser & Energy-Based Dermatology. Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comLaser Beauty Devices Market Is Booming Rapidly with Strong Demand By 2033 | Cynosure • Lumenis • Syneron Candela • CuteraCoherent Market Insights published a research report forecasting the Laser Beauty Devices market to experience rapid growth and strong demand through 2033. The analysis covers global trends, competitive landscapes, and segmentation for professional and home-use devices among key industry players including Cynosure, Lumenis, and Cutera. This publication serves as a strategic tool for market participants to assess future profitability and navigate industry dynamics.PR NewswireGlobal Body Contouring Market Set to Reach $9.1 Billion by 2024ResearchAndMarkets.com released a global market research report on July 4, 2019, stating that the body contouring market reached $6.1 billion in 2018 and is projected to grow to $9.1 billion by 2024, at a compound annual growth rate of 6.8%. The report identifies rising obesity rates, increased aesthetic awareness, technological advancements, and rising disposable incomes as key growth drivers, with non-invasive devices representing the largest segment and clinical research organizations accounting for the largest end-use share. North America leads the market, followed by Europe and Asia Pacific, with Cynosure, Meridian, Syneron Medical, Lumenis, and Alma Lasers identified as key players in the competitive landscape.PR NewswireSyneron Candela anuncia la adquisición de EllipseSyneron Candela announced the acquisition of Ellipse, a Danish manufacturer of medical devices specializing in intense pulsed light (IPL) and laser platforms for dermatological treatments. This strategic move aims to strengthen Syneron Candela's presence in the multi-application device market by integrating Ellipse's respected IPL technologies into its existing portfolio. The financial terms of the agreement were not disclosed.PR NewswireSyneron Candela annonce l'acquisition d'EllipseSyneron Candela has announced the acquisition of Ellipse, a Danish medical device manufacturer specializing in intense pulsed light (IPL) and laser technologies for aesthetic treatments. This transaction aims to expand Syneron Candela's portfolio of multi-application devices, combining its existing laser strengths with Ellipse's respected IPL platforms. Financial terms of the deal were not disclosed.PR NewswirePatent Infringement Suits Filed Today Against 18 Manufacturers and Distributors of Fractional RF Microneedle SystemsSyneron Medical Ltd and its subsidiary Candela Corporation, alongside Massachusetts General Hospital, filed patent infringement lawsuits against 18 manufacturers and distributors of fractional RF microneedle systems in U.S. federal court and the International Trade Commission. The legal action seeks to block the importation of competing products from companies such as Cutera, Invasix, and Lumenis, while pursuing damages for past infringement of patents originally developed by Dr. Dieter Manstein.PR NewswireOn Our Radar: The At-Home Beauty Tool RevolutionIluminage Beauty, a joint venture between Unilever and Syneron Medical, is launching new at-home beauty devices targeting the millennial market with products for hair removal, acne treatment, and anti-aging. The company cites a 14% annual growth in the at-home beauty tool sector driven by consumer demand for convenient, professional-grade treatments.PR NewswireSyneron Candela Announces New Technology and Indications at the 2017 American Academy of Dermatology (AAD) Annual MeetingSyneron Medical Ltd. announced new FDA clearances and technology expansions for its aesthetic devices, including PicoWay for acne scars and UltraShape Power for body contouring, at the 2017 American Academy of Dermatology meeting. The company highlighted that UltraShape Power delivers 20% more ultrasound power with a 30-minute average treatment time, while GentleTouch received CE mark approval as the first device combining Alexandrite and radiofrequency energies for hair removal.PR NewswireSyneron Medical to Participate in Leerink Partners 6th Annual Global Healthcare ConferenceSyneron Medical Ltd. announced that its Chief Financial Officer and the CEO of Syneron Candela North America will participate in the Leerink Partners 6th Annual Global Healthcare Conference on February 16, 2017 in New York City, including a fireside chat presentation. The conference will allow institutional investors to meet with company executives, and the presentation will be webcast live over the Internet with a 90-day replay available. Syneron Candela is a leading global aesthetic device company that markets products in 86 countries across body contouring, hair removal, wrinkle reduction, and other medical-aesthetic applications.PR NewswireSyneron Medical to Report Fourth Quarter and Full Year 2016 Financial Results on February 15, 2017Syneron Medical Ltd. announced that it will release its fourth quarter and full year 2016 financial results before the market opens on February 15, 2017. The company will host a conference call and live webcast to discuss these results, with access details provided for investors and analysts.PR NewswireCenter City Dermatology First In Center City Philadelphia To Offer Breakthrough, FDA-Cleared, Non-Invasive, UltraShape Power™ System For Fat DestructionCenter City Dermatology has become the first practice in Center City Philadelphia to offer UltraShape Power, a non-invasive fat destruction system developed by Syneron Candela. The FDA-cleared treatment uses focused ultrasound to target and destroy fat cells without damaging surrounding tissue, with clinical studies showing a 32% reduction in subcutaneous fat thickness.